is semaglutide off the fda shortage list 🚨 Ends FDA has officially declared an end to the shortage of semaglutide, the active ingredient in the popular medications Ozempic and Wegovy. This announcement signals a significant FDA Issues Order on Resolution

With orforglipron offering additional advantages such as the elimination of strict pre-dosing requirements, potential lower cost, and easier storage, it will be important to see whether these features lead to even greater adherence, says Priya Jaisinghani, a diabetes and obesity medicine specialist at NYU Langone

However, this does not exclude the possibility that the firm also produces prescription drug products and/or other finished drug products

Seizures Bupropion, a component of CONTRAVE, can cause seizures

From glucose lowering agents to disease/diabetes modifying drugs: a SIMPLE approach for the treatment of type 2 diabetes